Novavax, Inc. (NVAX) Latest Stock News & Headlines
Jul 1, 2022 · Get the latest Novavax, Inc. (NVAX) stock news and headlines to help you in your trading and investing decisions.
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML …
6 hours ago · Novavax incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 ...
Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut
1 day ago · More on NVAX’s Earnings. Novavax recorded $38.2 million in product sales compared with $2.2 million in the year-ago quarter. This upside was primarily driven by sales of the company’s protein ...
Novavax’s stock slides 7% as guidance cut offsets narrower-than ...
2 days ago · Novavax Inc.’s stock fell 4% Tuesday after the company cut its full-year guidance, offsetting a narrower-than-expected third-quarter loss and better-than-expected revenue.
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials ...
3 days ago · Novavax (NASDAQ: NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza ...
NVAX Stock Price | Novavax Inc. Stock Quote (U.S.: Nasdaq)
3 days ago · NVAX | Complete Novavax Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Novavax Advances Vaccine Strategy Amid Financial Shifts
2 days ago · Novavax ( (NVAX)) has released its Q3 earnings. Here is a breakdown of the information Novavax presented to its investors. Novavax, Inc., based in Gaithersburg, Maryland, is a global biotechnology ...
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML …
1 day ago · As the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory updates. Novavax (NVAX Quick Quote NVAX - Free Report) was in focus ...
Novavax Cuts FY24 Revenue View Below Market; Stock
2 days ago · In its third quarter, Novavax's net loss was $121.30 million, or $0.76 loss per share, compared to net loss of $130.78 million or $1.26 per share a year ago.
Novavax's Updated Protein-based COVID-19 Vaccine Now an ...
Nov 28, 2023 · Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Nuvaxovid™ XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) has been...
- Some results have been removed